Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – Ovarian suppression, using a luteinizing hormone-releasing hormone agonist, during neoadjuvant chemotherapy for breast cancer in premenopausal women does not help preserve subsequent ovarian…
Teresa L. Knight, MD, FACOG, Chief Medical Officer of the Women’s Health Specialists of Saint Louis, discusses the risks of inherited breast cancer gene mutations. To learn more…
NEW YORK (Reuters Health) –The theoretical advantages of stereotactic radiation therapy for treating tumors in the body have yet to be confirmed clinically — despite its widespread use…
NEW YORK (Reuters Health) – Long-term results confirm that use of neoadjuvant chemotherapy in treating muscle-invasive cancer of the bladder confers a significant survival advantage, an international collaborative…
NEW YORK (Reuters Health) – Contrary to previous findings, patients with advanced cancer do not have significantly improved survival when they are treated with a low-molecular-weight heparin, European…
NEW YORK (Reuters Health) – The combination of etanercept and cyclophosphamide might be a risky one in patients with Wegener’s Granulomatosis, especially with those who have long-term, chronic…
NEW YORK (Reuters Health) – In most patients with localized renal cancer, simple enucleation may provide results equivalent to those of standard partial nephrectomy, Italian researchers report in…
NEW YORK (Reuters Health) – For patients with advanced, untreated non-small-cell lung cancer, the American Society of Clinical Oncology recommends that the tumor be tested for genetic mutations…
NEW YORK (Reuters Health) – The risk of pancreatic malignancy is increased in patients with diabetes, researchers from Taiwan report in a pre-print version of a study that…
NEW YORK (Reuters Health) – In women with metastatic breast cancer, a longer duration of chemotherapy is associated with a clinically meaningful and statistically significant improvement in time…
